LONDON MARKET PRE-OPEN: Galliford Try Expects To Reinstate Dividends
LONDON MARKET PRE-OPEN: Galliford Try Expects To Reinstate Dividends
Read moreLONDON MARKET PRE-OPEN: Galliford Try Expects To Reinstate Dividends
Read more(Sharecast News) - Indivior said a US court approved its agreement with the Department of Justice and other agencies and dismissed charges related to sales of its Suboxone opioid addiction treatment.
Read more(Sharecast News) - Indivior reported a decline in third-quarter revenue and operating profit on Thursday but reinstated financial guidance as it said it expects to be profitable on an adjusted pre-tax basis for FY 2020.
Read moreIndivior Reinstates Annual Guidance; Quarterly Profit Falls 79%
Read moreIndivior Says Former CEO Thaxter's US Sentencing Not Related
Read more(Sharecast News) - Pharmaceutical firm Indivior revealed on Friday that former chief executive Shaun Thaxter had been sentenced in United States Federal Court.
Read moreUK Earnings, Trading Statements Calendar - Next 7 Days
Read moreIndivior Reorganises Amid Challenges; Still In Line With Expectations
Read more(Sharecast News) - Opioid addiction treatment maker Indivior outlined plans on Thursday to reduce costs through job cuts and restructuring, as it looks to support long-term growth ambitions and protect its financial and operational flexibility in response to the pandemic.
Read moreIN BRIEF: Indivior Chair Howard Pien Steps Down Immediately
Read moreTOP NEWS: ITV Bumped From FTSE 100 For B&M European Value Retail
Read moreC4X Discovery Joins Covid Collaboration With Italian Hospitals
Read moreIN BRIEF: Indivior Swings To Loss As It Loses Suboxone Market Share
Read more(Sharecast News) - Indivior suffered a precipitous drop in sales and profits over the first half as the Covid-19 pandemic saw the number of new patients in the US for its anti-opioid addiction drug dry up.
Read more(Sharecast News) - Indivior: Jefferies upgrades to buy with a target price of 200.0p.
Read more